Astrana Health, Inc.

ASTHNASDAQHealthcareMedical Care Facilities

$37.23- (-)1Y +14.63%

As of Oct 26, 2026 close

Market cap: $1.85B
P/E (TTM): 45.71
Forward P/E: 28.88
Dividend yield: -
52-week range: $18.08$51.60
Volume (live): -
Avg. volume (3M): 387.19K

Astrana Health, Inc. (ASTH) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Astrana Health, Inc. stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Buy

Based on 9 unique analysts

(12 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$52.40

+40.75% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest ASTH Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 9, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Oct 7, 2026	Andrew Mok CFA	Barclays	Maintains	Buy	$53.00
Oct 1, 2026	Eugene Mannheimer	Freedom Capital	Reiterates	Buy	$50.00
Sep 29, 2026	Jailendra Singh	Truist	Maintains	Buy	-
Sep 15, 2026	Michael Wiederhorn	Oppenheimer	Initiates	Buy	$53.00
Aug 28, 2026	Andrew Mok CFA	Barclays	Maintains	Buy	$53.00
Aug 10, 2026	David Larsen	BTIG	Maintains	Buy	$65.00
Aug 9, 2026	David Larsen	BTIG	Maintains	Buy	$65.00
Aug 7, 2026	Ryan Daniels	William Blair	Maintains	Buy	-
Aug 7, 2026	Matthew Gillmor CFA	KeyBanc	Maintains	Hold	-
Aug 7, 2026	Matthew Shea	Needham	Reiterates	Buy	$41.00
Aug 6, 2026	Ryan Daniels	William Blair	Maintains	Buy	-

Zacks Equity Research

HoldInitiates Coverage

Oct 9

Andrew Mok CFA

Barclays

BuyMaintains

$53.00

Oct 7

Eugene Mannheimer

Freedom Capital

BuyReiterates

$50.00

Oct 1

Jailendra Singh

Truist

BuyMaintains

Sep 29

Michael Wiederhorn

Oppenheimer

BuyInitiates

$53.00

Sep 15

Andrew Mok CFA

Barclays

BuyMaintains

$53.00

Aug 28

David Larsen

BTIG

BuyMaintains

$65.00

Aug 10

David Larsen

BTIG

BuyMaintains

$65.00

Aug 9

Ryan Daniels

William Blair

BuyMaintains

Aug 7

Matthew Gillmor CFA

KeyBanc

HoldMaintains

Aug 7

Matthew Shea

Needham

BuyReiterates

$41.00

Aug 7

Ryan Daniels

William Blair

BuyMaintains

Aug 6

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ASTH?

The analyst consensus rating for ASTH is Buy, based on the latest ratings from 9 analysts over the last 90 days.

What is the average price target for ASTH?

The average 12-month price target for ASTH is $52.40, representing an upside of 40.7% from the Oct 26, 2026 close of $37.23.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.